These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20836085)

  • 21. Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cells.
    Spahr CS; Daris ME; Graham KC; Soriano BD; Stevens JL; Shi SD
    MAbs; 2018; 10(8):1291-1300. PubMed ID: 30148415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near-UV and Visible Light Degradation of Iron (III)-Containing Citrate Buffer: Formation of Carbon Dioxide Radical Anion via Fragmentation of a Sterically Hindered Alkoxyl Radical.
    Zhang Y; Richards DS; Grotemeyer EN; Jackson TA; Schöneich C
    Mol Pharm; 2022 Nov; 19(11):4026-4042. PubMed ID: 36074094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations.
    Poole RA; Kasper PT; Jiskoot W
    J Pharm Sci; 2011 Jul; 100(7):3018-22. PubMed ID: 21547912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of stable isotope incorporation into recombinant proteins.
    Zhang X; Luo Q; Apostol I; Luo S; Jerums M; Huang G; Jiang XG; Gastwirt J; Savjani N; Lewis J; Keener R; Wypych J
    Anal Biochem; 2013 Feb; 433(2):137-49. PubMed ID: 23085118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-fucosylation of an antibody light chain: characterization of a modification occurring on an IgG1 molecule.
    Valliere-Douglass JF; Brady LJ; Farnsworth C; Pace D; Balland A; Wallace A; Wang W; Treuheit MJ; Yan B
    Glycobiology; 2009 Feb; 19(2):144-52. PubMed ID: 18952827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the conserved oligosaccharides of recombinant monoclonal antibodies on the separation by protein A and protein G chromatography.
    Gaza-Bulseco G; Hickman K; Sinicropi-Yao S; Hurkmans K; Chumsae C; Liu H
    J Chromatogr A; 2009 Mar; 1216(12):2382-7. PubMed ID: 19181325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation.
    Gopalrathnam G; Sharma AN; Dodd SW; Huang L
    PDA J Pharm Sci Technol; 2018; 72(2):163-175. PubMed ID: 29343621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O-linked glucosylation of a therapeutic recombinant humanised monoclonal antibody produced in CHO cells.
    Tanaka M; Koga A; Kobe A; Sekimori Y; Aso Y; Terada K
    Eur J Pharm Biopharm; 2013 Feb; 83(2):123-30. PubMed ID: 23183444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of recombinant monoclonal IgG2 antibodies using LC-MS and limited Lys-C digestion.
    Nowak C; Patel R; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():15-18. PubMed ID: 29879591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of monoclonal antibody product heterogeneity resulting from alternate cleavage sites of signal peptide.
    Kotia RB; Raghani AR
    Anal Biochem; 2010 Apr; 399(2):190-5. PubMed ID: 20074542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
    Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamine deamidation of a recombinant monoclonal antibody.
    Liu H; Gaza-Bulseco G; Chumsae C
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4081-8. PubMed ID: 19021137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studies.
    Kessler N; Zvi A; Ji M; Sharon M; Rosen O; Levy R; Gorny M; Zolla-Pazner S; Anglister J
    Protein Expr Purif; 2003 Jun; 29(2):291-303. PubMed ID: 12767822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior.
    Quan C; Alcala E; Petkovska I; Matthews D; Canova-Davis E; Taticek R; Ma S
    Anal Biochem; 2008 Feb; 373(2):179-91. PubMed ID: 18158144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification.
    Borlido L; Moura L; Azevedo AM; Roque AC; Aires-Barros MR; Farinha JP
    Biotechnol J; 2013 Jun; 8(6):709-17. PubMed ID: 23420794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-terminal modification of monoclonal antibody drugs: amidated species as a general product-related substance.
    Tsubaki M; Terashima I; Kamata K; Koga A
    Int J Biol Macromol; 2013 Jan; 52():139-47. PubMed ID: 23022270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
    Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
    Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.
    Gaza-Bulseco G; Faldu S; Hurkmans K; Chumsae C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):55-62. PubMed ID: 18567545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of recombinant monoclonal antibody variants detected by hydrophobic interaction chromatography and imaged capillary isoelectric focusing electrophoresis.
    King C; Patel R; Ponniah G; Nowak C; Neill A; Gu Z; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():96-103. PubMed ID: 29649755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to Photo-degradation of
    Prajapati I; Larson NR; Choudhary S; Kalonia C; Hudak S; Esfandiary R; Middaugh CR; Schöneich C
    Mol Pharm; 2021 Sep; 18(9):3223-3234. PubMed ID: 34482697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.